SNHG12 binds to the transcription factor SP1 and blocks its ubiquitylation and degradation, and SP1 directly binds to the CDCA3 gene promoter and enhances its transcription, leading to RCC cell proliferation, migration, invasion and resistance to sunitinib treatment. Here, SP1 is linked to renal cell carcinoma.